v

I

VAN SCHAIK , Ivo N

Last name: VAN SCHAIK

First name: Ivo N

2018 (v1)

Publication

Metadata-only

Intravenous versus subcutaneous immunoglobulin – Authors' reply

van Schaik, Ivo N Mielke, Orell Sabet, Arman

No description

Uploaded on: March 27, 2023
2018 (v1)

Publication

Metadata-only

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

van Schaik, Ivo N Bril, Vera van Geloven, Nan

Background Approximately two-thirds of patients with chronic inflammatory demyelinating polyneuropathy (CIDP) need long-term intravenous immunoglobulin. Subcutaneous immunoglobulin (SCIg) is an alternative option for immunoglobulin delivery, but has not previously been investigated in a large trial of CIDP. The PATH study compared relapse rates...

Uploaded on: April 14, 2023